Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LONA compared with IKT: revenue, margins and what each company keeps, and the suppliers and customers both name
LONA
LeonaBio, Inc.
Change
Mkt cap
Revenue
Revenue
IKT
Inhibikase Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LONA
LeonaBio, Inc.
vs
IKT
Inhibikase Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
LONA, solid
IKT, dashed
Supply-chain overlap
Revenue flow
LONA: latest quarter not drawable. IKT: latest quarter is a loss; flow not drawable.
Method
›
LONA
LeonaBio, Inc.
Change
4.80
· pre 4.80
· delayed
Mkt cap
$46.5M
Revenue
—
IKT
Inhibikase Therapeutics, Inc.
Change
1.55
· pre 1.53
· delayed
Pre-market
Oct 30 '26
delayed
Mkt cap
$216.3M
Revenue
$79,569
Q3 FY23
vs
Compare
Pre-market
Oct 30 '26
delayed
LONA
LeonaBio, Inc.
vs
IKT
Inhibikase Therapeutics, Inc.
4.80
pre 4.80
delayed
Price
1.55
pre 1.53
delayed
$46.5M
Mkt cap
$216.3M
—
Revenue
$79,569
Q3 FY23
Change
Change
LONA
4.80
vs
IKT
1.55
Pre-market
Oct 30 '26
delayed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only LONA
6
LGND
Ligand Pharmaceuticals
supplier
—
AnswerALS consortium
unlisted
supplier
—
Sermonix
unlisted
supplier
—
Sermonix Pharmaceuticals
unlisted
supplier
2 more · LONA chain
›
Shared
0
No disclosed counterparties: IKT.
Only IKT
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR